Medicus Pharma Warrant
MDCXW
4 hedge funds and large institutions have $63.6K invested in Medicus Pharma Warrant in 2026 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
6.4% less ownership
Funds ownership: 17.68% → 11.28% (-6.4%)
33% less funds holding
Funds holding: 6 → 4 (-2)
47% less capital invested
Capital invested by funds: $120K → $63.6K (-$56.5K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$341 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$27.4K |
| 2 |
EAM
Empery Asset Management
New York
|
-$11.5K |
MDCXW Hedge Fund Activity: Q2 2026 in Review
4 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Medicus Pharma Warrant (MDCXW) for Q2 2026, worth a combined $63.6K — down 47% from $120K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MDCXW and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $341. The largest seller was Private Advisor Group, exiting entirely with an estimated $27.4K sold.
- 4 institutional investors held Medicus Pharma Warrant (MDCXW) as of Q2 2026, down from 6 in Q1 2026.
- Funds reported $63.6K of Medicus Pharma Warrant stock for Q2 2026, down 47% quarter-over-quarter.
- 0 funds opened new Medicus Pharma Warrant positions in Q2 2026 and 2 closed out, a net change of -2 holders.
- The largest Medicus Pharma Warrant buyer in Q2 2026 was UBS Group, an estimated $341 added.
- The largest Medicus Pharma Warrant seller in Q2 2026 was Private Advisor Group, an estimated $27.4K sold.
Based on aggregated 13F filings for Q2 2026.